A Study of Durvalumab Plus Tremelimumab With Chemotherapy in Untreated ES-SCLC
Clinical trial NCT03963414 · TERMINATED
Trial details
- NCT number
- NCT03963414
- Sponsor
- University of Nebraska
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2021-12-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.